• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强啡肽肽及其受体的结构与动力学。

Structure and dynamics of dynorphin peptide and its receptor.

机构信息

Institut de Pharmacologie et de Biologie Structurale (IPBS, CNRS UPS), Université de Toulouse, Toulouse, France.

Institut de Pharmacologie et de Biologie Structurale (IPBS, CNRS UPS), Université de Toulouse, Toulouse, France.

出版信息

Vitam Horm. 2019;111:17-47. doi: 10.1016/bs.vh.2019.05.006. Epub 2019 Jun 29.

DOI:10.1016/bs.vh.2019.05.006
PMID:31421700
Abstract

Dynorphin is a neuropeptide involved in pain, addiction and mood regulation. It exerts its activity by binding to the kappa opioid receptor (KOP) which belongs to the large family of G protein-coupled receptors. The dynorphin peptide was discovered in 1975, while its receptor was cloned in 1993. This review will describe: (a) the activities and physiological functions of dynorphin and its receptor, (b) early structure-activity relationship studies performed before cloning of the receptor (mostly pharmacological and biophysical studies of peptide analogues), (c) structure-activity relationship studies performed after cloning of the receptor via receptor mutagenesis and the development of recombinant receptor expression systems, (d) structural biology of the opiate receptors culminating in X-ray structures of the four opioid receptors in their inactive state and structures of MOP and KOP receptors in their active state. X-ray and EM structures are combined with NMR data, which gives complementary insight into receptor and peptide dynamics. Molecular modeling greatly benefited from the availability of atomic resolution 3D structures of receptor-ligand complexes and an example of the strategy used to model a dynorphin-KOP receptor complex using NMR data will be described. These achievements have led to a better understanding of the complex dynamics of KOP receptor activation and to the development of new ligands and drugs.

摘要

脑啡肽是一种参与疼痛、成瘾和情绪调节的神经肽。它通过与κ阿片受体(KOP)结合发挥作用,KOP 属于 G 蛋白偶联受体大家族。脑啡肽肽于 1975 年被发现,其受体于 1993 年被克隆。本文将描述:(a)脑啡肽及其受体的活性和生理功能,(b)受体克隆前进行的早期结构-活性关系研究(主要是肽类似物的药理学和生物物理学研究),(c)受体克隆后通过受体诱变和重组受体表达系统的发展进行的结构-活性关系研究,(d)阿片受体的结构生物学,最终得到四个阿片受体在非活性状态下的 X 射线结构以及 MOP 和 KOP 受体在活性状态下的结构。X 射线和 EM 结构与 NMR 数据相结合,为受体和肽的动力学提供了互补的见解。分子建模极大地受益于配体复合物的原子分辨率 3D 结构的可用性,并且将描述使用 NMR 数据对脑啡肽-KOP 受体复合物进行建模的策略的示例。这些成就使我们更好地了解 KOP 受体激活的复杂动力学,并开发了新的配体和药物。

相似文献

1
Structure and dynamics of dynorphin peptide and its receptor.强啡肽肽及其受体的结构与动力学。
Vitam Horm. 2019;111:17-47. doi: 10.1016/bs.vh.2019.05.006. Epub 2019 Jun 29.
2
The nociceptin (ORL1) receptor: molecular cloning and functional architecture.孤啡肽(ORL1)受体:分子克隆与功能结构
Peptides. 2000 Jul;21(7):893-900. doi: 10.1016/s0196-9781(00)00225-4.
3
NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.与人类κ阿片受体结合的激动剂强啡肽肽的核磁共振结构与动力学
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11852-7. doi: 10.1073/pnas.1510117112. Epub 2015 Sep 8.
4
Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.阿片肽[D-Ala8]强啡肽A-(1-11)NH2中苯丙氨酸4被取代的影响。
J Med Chem. 2003 Sep 11;46(19):4002-8. doi: 10.1021/jm030075o.
5
Chemotype-selective modes of action of κ-opioid receptor agonists.κ 阿片受体激动剂的化学型选择性作用模式。
J Biol Chem. 2013 Nov 29;288(48):34470-83. doi: 10.1074/jbc.M113.515668. Epub 2013 Oct 11.
6
NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles.强啡肽A(1-17)与十二烷基磷酸胆碱胶束结合的核磁共振及结构模型
Biochemistry. 1997 Feb 25;36(8):1971-81. doi: 10.1021/bi961457h.
7
Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.强啡肽A(1-11)-NH2第3位残基修饰对κ受体选择性和效价的影响。
J Med Chem. 1996 Jun 21;39(13):2456-60. doi: 10.1021/jm950655o.
8
Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.强啡肽A-(1-10)与κ-阿片受体细胞外环2结合的分子模拟。受体激活模型。
J Med Chem. 1997 Sep 26;40(20):3254-62. doi: 10.1021/jm970252j.
9
The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.强啡肽片段在转染的人胚肾细胞(HEK)以及单侧外周炎症动物模型中对κ、μ和δ阿片受体的作用效果。
Peptides. 2017 Mar;89:9-16. doi: 10.1016/j.peptides.2016.12.019. Epub 2016 Dec 31.
10
Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs.通过使用化学活化的含硫醇强啡肽A类似物进行二硫键亲和标记,探索三种阿片受体亚型结合位点中的通用半胱氨酸。
J Biochem. 1999 Jul;126(1):254-9. doi: 10.1093/oxfordjournals.jbchem.a022430.

引用本文的文献

1
Label-free, real-time monitoring of membrane binding events at zeptomolar concentrations using frequency-locked optical microresonators.使用频锁光学微谐振器在皮摩尔浓度下对膜结合事件进行无标记、实时监测。
Nat Commun. 2024 Aug 28;15(1):7445. doi: 10.1038/s41467-024-51320-x.
2
Mechanisms Underlying Sex Differences in Temporomandibular Disorders and Their Comorbidity with Migraine.颞下颌关节紊乱症性别差异及其与偏头痛共病的潜在机制
Brain Sci. 2024 Jul 15;14(7):707. doi: 10.3390/brainsci14070707.
3
Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases.
下丘脑弓状核:解剖学、生理学及疾病
Exp Neurobiol. 2023 Dec 31;32(6):371-386. doi: 10.5607/en23040.
4
Label-free, real-time monitoring of membrane binding events at zeptomolar concentrations using frequency-locked optical microresonators.使用锁频光学微谐振器对zeptomolar浓度下的膜结合事件进行无标记实时监测。
bioRxiv. 2023 Sep 22:2023.09.20.558657. doi: 10.1101/2023.09.20.558657.
5
Cryo-EM structure of human κ-opioid receptor-Gi complex bound to an endogenous agonist dynorphin A.结合内源性激动剂强啡肽A的人κ-阿片受体-Gi复合物的冷冻电镜结构
Protein Cell. 2023 Jun 7;14(6):464-468. doi: 10.1093/procel/pwac033.
6
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects.κ-阿片受体激动剂的设计,旨在开发潜在的疼痛治疗药物,减少副作用。
Molecules. 2023 Jan 1;28(1):346. doi: 10.3390/molecules28010346.
7
Global insights into the fine tuning of human AAR conformational dynamics in a ternary complex with an engineered G protein viewed by NMR.通过 NMR 观察到的与工程化 G 蛋白形成三元复合物时人类 AAR 构象动力学的精细调节的全球洞察。
Cell Rep. 2022 Dec 20;41(12):111844. doi: 10.1016/j.celrep.2022.111844.
8
High-throughput characterization of photocrosslinker-bearing ion channel variants to map residues critical for function and pharmacology.高通量表征带有光交联剂的离子通道变体,以绘制对功能和药理学至关重要的残基图谱。
PLoS Biol. 2021 Sep 7;19(9):e3001321. doi: 10.1371/journal.pbio.3001321. eCollection 2021 Sep.
9
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.κ 阿片受体配体和药理学:二苯乙基胺,一类结构独特、选择性 κ 阿片受体配体。
Handb Exp Pharmacol. 2022;271:163-195. doi: 10.1007/164_2020_431.
10
Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities.二苯乙基胺类化合物作为选择性 κ 阿片受体配体的发展及其药理学活性。
Molecules. 2020 Nov 2;25(21):5092. doi: 10.3390/molecules25215092.